Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pearson, J E
Right arrow Articles by Silman, A J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pearson, J E
Right arrow Articles by Silman, A J
Annals of the Rheumatic Diseases 2003;62:697-699
© 2003 by BMJ Publishing Group & European League Against Rheumatism

LEADER

Scleroderma

Risk of cancer in patients with scleroderma

J E Pearson , A J Silman

ARC Epidemiology Unit, School of Epidemiology and Health Sciences, University of Manchester, Room 2.514, Stopford Building, Oxford Road, Manchester M13 9PT, UK

Correspondence to:
Correspondence to:
Professor A Silman;
alan.silman@man.ac.uk

Risk of cancer may be slightly increased, but extra screening is not necessary

Keywords: scleroderma; cancer; cohort study

The first 150 words of the full text of this article appear below.

The first report linking cancer with scleroderma (Scl) was 50 years ago when a case of alveolar cell carcinoma was described.1 Since then there have been several further case reports and series linking Scl with cancer at various sites.2 The sites of cancer most frequently reported are the lung3,4 and breast5 (perhaps reflecting their prevalence in the general population), but cancers at other sites have also been reported.2,6 In this issue of the Annals there is a report of an Australian population study on Scl and cancer.7 The authors showed a doubling in the risk of all cancers over an average six year follow up period, with the lung being the site at greatest risk. It is thus timely to consider all the evidence suggesting this association is real and then explore some of the possible underlying explanations.


IS THERE AN ASSOCIATION?
It is necessary to compare the incidence of cancer occurring in . . . [Full text of this article]




This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
E. K Pontifex, C. L Hill, and P. Roberts-Thomson
Risk factors for lung cancer in patients with scleroderma: a nested case-control study
Ann Rheum Dis, April 1, 2007; 66(4): 551 - 553.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
K. E. Smedby, H. Hjalgrim, J. Askling, E. T. Chang, H. Gregersen, A. Porwit-MacDonald, C. Sundstrom, M. Akerman, M. Melbye, B. Glimelius, et al.
Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype
J Natl Cancer Inst, January 4, 2006; 98(1): 51 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. Mittal, P. Maddison, and W. Williams
Systemic sclerosis, morphoea and breast cancer
Rheumatology, January 1, 2006; 45(1): 119 - 120.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
S. Bernatsky, A. Clarke, R. Ramsey-Goldman, L. Joseph, J.-F. Boivin, R. Rajan, A. D. Moore, M.-H. Leung, A. Allen, and C. Gordon
Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus
Rheumatology, September 1, 2004; 43(9): 1178 - 1181.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & European League Against Rheumatism